BioCentury
ARTICLE | Clinical News

Flibanserin regulatory update

May 18, 2015 7:00 AM UTC

FDA’s Bone, Reproductive and Urologic Drugs and Drug Safety and Risk Management advisory committees will meet on June 4 to discuss a resubmitted NDA from Sprout for flibanserin to treat hypoactive sex...